Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

COVID-19-positive patients with prosthetic speech implants face increased risks and need special care.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

A genetic region near the PAX1 gene is linked to a higher risk of scoliosis in females.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Effective scalp reconstruction requires a wide range of surgical skills and an understanding of hair biology.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Finasteride increases hair count and improves hair growth with low risk of side effects.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Surgery is the main treatment for liver hydatidosis, but has risks; albendazole is the most effective drug but can have side effects.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

A cosmetic procedure can lower the hairline by up to 10 cm, with high satisfaction but potential for temporary sensation loss and rare risks.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Nanoparticles can speed up wound healing and deliver drugs effectively but may have potential toxicity risks.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Beard hair transplantation is generally satisfying, requires 250-800 grafts, uses FUE to avoid scars, needs careful planning, has some risks, and hair regrowth starts after 4-6 months.

Artificial hair implants can quickly improve looks and life quality, but they have risks like infection and early fiber loss, so more research is needed to confirm their safety and effectiveness.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

Intraoperative corticosteroids reduce swelling, and early care lowers folliculitis risk in hair transplant donor sites.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Finasteride is a cost-effective option for treating BPH, reducing risk of urinary issues and surgery.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Women with AGA have higher lipid levels, increasing heart disease risk.